23
Nov
2026

Loxim Industries Limited

Exhibitor at CPHI India 2026 stand 2N53
About Us

LOXIM is confidently leveraging its decades of expertise in chemistry as it expands into the pharmaceutical industry. Our commitment to innovation and precision in chemistry enables us to offer a comprehensive range of APIs, Intermediates, and CMO & CDMO capabilities to meet the needs of the global pharmaceutical market. Our top-tier R&D facility can handle complex chemical synthesis, analytical methods development, and testing. LOXIM aims to be a responsible business, adding value through its core competency in chemistry while adhering to its core values.

  • Country/Region:
    India
  • Founded:
    1977
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
API Producer
Custom Manufacturing/Custom Synthesis
Intermediates Manufacturer
Contact info
Event information
CPHI India 2026
  • 23 Nov 2026 - 25 Nov 2026
  • IICC, Yashobhoomi, Dwarka, Delhi
  • Visit us at stand 2N53

Products Featured at CPHI India 2026

  • Empagliflozin

    Product Empagliflozin

    (S)-3-(4-(5-Bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran (Empagliflozin Bromo compound)
  • Apixaban

    Product Apixaban

    CAS No. 1267610-26-3
    1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone

    CAS No. 27143-07-3
    Ethyl-2-chloro-2-(2-(4-methoxyphenyl)hydrazineylidene)acetate 
  • Montelukast

    Product Montelukast

    CAS No. 287930-77-2
    2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-propanol

    CAS No.  162515-68-6
    [1-(Mercaptomethyl)cyclopropyl]acetic acid

Loxim Industries Limited Resources (1)